Digitoxin
Tags:
drug
small molecule
PubChem: 441207 441207 Related interactions
Related publications
Title
Author
Type
Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapy. Harvey B Pollard, Bette S. Pollard, John R. Pollard
Research
Computational Guided Drug Repurposing for Targeting 2'-O-Ribose Methyltransferase of SARS-CoV-2 Kedar Sharma, Sudhir Morla, Arun Goyal, Sachin Kumar
Research
Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs Jeon, Sangeun and Ko, Meehyun and Lee, Jihye and Choi, Inhee and Byun, Soo Young and Park, Soonju and Shum, David and Kim, Seungtaek
Research
Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches Hourieh Kalhor, Solmaz Sadeghi, Hoda Abolhasani, Reyhaneh Kalhor, Hamzeh Rahimi
Research
Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor Tamim Ahsana, Abu Ashfaqur Sajib
Research
In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy Tian-zi Wei, Hao Wang, Xue-qing Wu, Yi Lu, Sheng-hui Guan, Feng-quan Dong, Chen-le Dong, Gu-li Zhu, Yu-zhou Bao, Jian Zhang, Guan-yu Wang & Hai-ying Li
Research
In Silico Screening of the DrugBank Database to Search for Possible Drugs against SARS-CoV-2 Sebastián A. Cuesta , José R. Mora, Edgar A. Márquez
Research
Target
Target affiliation
Drug
Type
Result
Target
Target affiliation
Drug
Type
Result
Name
Synonyms
Genes
Origin
Name
Synonyms
Genes
Origin
Name
Synonyms
PubChem
DrugBank
RCSB PDB
ATC
Name
Synonyms
PubChem
DrugBank
RCSB PDB
ATC
Title
Authors
DOI
Source
Article type
Date
Title
Authors
DOI
Source
Article type
Date
Title
Status
Phases
Start Date
Prim. Comp. Date
Comp. Date
First Post. Date
Title
Status
Phases
Start Date
Prim. Comp. Date
Comp. Date
First Post. Date
CORDITE (CORona Drug InTEractions database) collects and aggregates data from PubMed, MedRxiv, BioRxiv, ChemRxiv and PMC for SARS-CoV-2. Its main focus is set on drug interactions either addressing viral proteins or human proteins that could be used to treat COVID.
It collects and provides up-to-date information on computational predictions, in vitro, as well as in vivo study data.
The information provided is for research only and we cannot guarantee the correctness of the data.
Please contact dominik.heider@uni-muenster.de for further information.
Programmable access
There is an open API for access programmatically to the database. The API will print a JSON output:
Interactions
https://cordite-api.uni-muenster.de/api.php?action=list&table=interaction Targets
https://cordite-api.uni-muenster.de/api.php?action=list&table=target Drugs
https://cordite-api.uni-muenster.de/api.php?action=list&table=drug Publications
https://cordite-api.uni-muenster.de/api.php?action=list&table=publication Clinical trials
https://cordite-api.uni-muenster.de/api.php?action=list&table=clinical_trial
